Biosurgery

Our Biosurgery division leads the way in medical innovation with Tachosil, our flagship hemostasis product. TachoSil is a closed-cell collagen matrix that has both hemostatic and air/liquid-tight properties. It is coated with human fibrinogen and human thrombin. Our priority is your success: Every choice made in the operating room is critical, leaving no room for uncertainty or compromise.

Risk factors for bleeding

There are several risk factors that affect the hemostatic processes and therefore influence the likelihood and intensity of bleeds during a surgical procedure. Medications affecting coagulation and malignancies are the most frequent risk factors.

The impact of bleeding complications and blood transfusions on hospital costs and treatment outcomes

Where we operate

With headquarters in the US, Switzerland, and China, our manufacturing capabilities span 7 locations across the globe.

SHARE: